ArticleFrontiers in immunology2022

PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.

Ke Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.